FDA Drug recall D-0436-2017
HCG (Chorionic Gonadotropin Lyopholized) II, 1000 unit vial, Rx only, Prepared by Town & Country, Compounding & Consultation Services, 106…
- FDA Drug
- Class III
- terminated
- Published 2017-01-25
On 2017-01-25 the FDA classified a Class III recall of HCG (Chorionic Gonadotropin Lyopholized) II, 1000 unit vial, Rx only, Prepared by Town & Country, Compounding & Consultation Services, 106… by Town And Country Compounding And Consultation Services, citing subpotent Drug: due to failed potency results of 74% (spec. 80-125%).
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0436-2017 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2016-10-18 |
| Published | 2017-01-25 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Town And Country Compounding And Consultation Services |
| Distribution | US |
Product
HCG (Chorionic Gonadotropin Lyopholized) II, 1000 unit vial, Rx only, Prepared by Town & Country, Compounding & Consultation Services, 106 Prospect St - 1st FL, Ridgewood, NJ 07459
Reason
Subpotent Drug: due to failed potency results of 74% (spec. 80-125%).
Identifiers
| code_info | Lot #: 05272016@17 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0436-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.